Simplex Trading
RXRX icon

Simplex Trading’s Recursion Pharmaceuticals RXRX Stock Holding History

Simplex Trading’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$931K Buy
+303,200
New +$1.17M ﹤0.01% 2575
2025
Q4 		– Sell
-704,700
Closed -$3.44M – 9863
2025
Q3 		$3.44M Buy
704,700
+218,400
+45% +$1.15M ﹤0.01% 1801
2025
Q2 		$2.46M Sell
486,300
-219,800
-31% -$1.08M ﹤0.01% 1923
2025
Q1 		$3.73M Buy
706,100
+126,400
+22% +$921K ﹤0.01% 1507
2024
Q4 		$3.92M Buy
579,700
+409,800
+241% +$2.76M ﹤0.01% 1653
2024
Q3 		$1.12M Sell
169,900
-91,900
-35% -$659K ﹤0.01% 2828
2024
Q2 		$1.96M Buy
261,800
+11,900
+5% +$104K ﹤0.01% 2222
2024
Q1 		$2.49M Buy
249,900
+144,600
+137% +$1.61M ﹤0.01% 2184
2023
Q4 		$1.04M Buy
105,300
+5,900
+6% +$42.1K ﹤0.01% 2971
2023
Q3 		$760K Buy
99,400
+70,100
+239% +$699K ﹤0.01% 2955
2023
Q2 		$218K Buy
29,300
+19,100
+187% +$134K ﹤0.01% 4198
2023
Q1 		$68K Buy
10,200
+9,900
+3,300% +$78.5K ﹤0.01% 5578
2022
Q4 		$2K Sell
300
-3,800
-93% -$37.3K ﹤0.01% 8636
2022
Q3 		$43K Sell
4,100
-1,900
-32% -$19.2K ﹤0.01% 6652
2022
Q2 		$48K Sell
6,000
-17,800
-75% -$119K ﹤0.01% 6558
2022
Q1 		$170K Buy
23,800
+20,700
+668% +$220K ﹤0.01% 5384
2021
Q4 		$53K Buy
3,100
+3,000
+3,000% +$56.4K ﹤0.01% 7197
2021
Q3 		$3K Buy
+100
New +$2.83K ﹤0.01% 9454

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's RXRX Position: Q1 2026 in Review

Simplex Trading opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 97,118 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #3826 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RXRX as recently as Q1 2025.

Simplex Trading first reported a position in RXRX in Q2 2021 and has held it in 15 quarters since. The position peaked at $2.54M in Q1 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Simplex Trading held 97,118 shares of Recursion Pharmaceuticals worth $298K as of Q1 2026.
  • Recursion Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3826 holding.
  • Simplex Trading first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • Simplex Trading's Recursion Pharmaceuticals position peaked at $2.54M in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.